Clinical Trial Update: Phase 1b/2a Unblinded Study of Responses in Premenopausal Women With HSDD to Lorexys Evaluating Efficacy and Safety [Phase 1, Phase 2]

View source ↗

Summary

Phase 1b/2a unblinded study evaluating efficacy and safety of Lorexys in premenopausal women with hypoactive sexual desire disorder and sexual interest/arousal …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoactive Sexual Desire Disorder
• Sexual Interest Arousal Disorder

Drugs mentioned

• Lorexys

Snippet

Sponsor: S1 Biopharma, Inc. | Conditions: Hypoactive Sexual Desire Disorder (DSM-IV-TR Defined), Sexual Interest/Arousal Disorder (DSM-5 Defined) | Phase 1, Phase 2 | Status: COMPLETED